Manganese (Mn) is an essential element necessary for normal growth and several critical body functions. It is normally found in mammalian tissues at micromolar concentrations (Rehnberg et al., 1982) . The pool of Mn in the body is tightly maintained through homeostatic mechanisms that regulate Mn absorption in the gastrointestinal (GI) tract and biliary Mn excretion. However, this essential metal can reach toxic tissue concentrations when the balance between uptake and excretion is altered due to excessive intake or compromised elimination of this metal. Such conditions include oral intake of high-dose Mn, inhalation of a high concentration of Mn, parenteral administration of Mn, or disease states with markedly reduced hepatobiliary function (Aschner et al., 2005) . Mn-induced neurotoxicity has been reported in laboratory animals and humans under these situations (Aschner et al., 2005) .
Mn-induced central nervous system toxicity is often associated with the chronic inhalation of high concentrations of airborne Mn (! 1 mg/m 3 ), which may occur in some occupational situations such as Mn mines, battery-producing plants, and certain other workplaces (Dorman et al., 2006) . In humans, Mn neurotoxicity results in a Parkinson-like motor dysfunction syndrome and neuropsychiatric symptoms (Aschner et al., 2005) . Evidence from exposed humans and nonhuman primates indicates that these responses are correlated with a selective increase of Mn in the striatum, globus pallidus, and related brain regions (Aschner et al., 2005) .
Concerns for Mn neurotoxicity in potentially susceptible subpopulations such as infants and children have been raised based on potential differences in Mn kinetics in these life stages compared to adults (Aschner et al., 2005) . Dorman et al. (2005a,b) investigated the pharmacokinetics of Mn in rats relevant for these subpopulations. Several studies have been published regarding Mn exposure through high-dose oral gavage (Dorman et al., 2006) , but information has been limited for pharmacokinetics of inhaled Mn in developing animals. Dorman et al. (2005b) reported that the inhaled Mn tissue dosimetry in neonatal animals is dependent on Mn exposure concentration and the age of the animal. There are several biological processes that are likely to account for the observed pharmacokinetic differences between adults and growing animals. These include Mn uptake, excretion, and tissue distribution (Aschner et al., 2005) . Proper evaluation of potential risks in early life stages requires a thorough understanding of both tissue dosimetry and dose-response relationships of Mn in target sites. To assess Mn tissue dosimetry in young animals, several factors should be considered, such as maternal tissue dosimetry, Mn transfer through milk, kinetic differences between the mother and neonates, developmental changes in Mn requirements in different tissues, and maturation processes related to Mn homeostatic mechanisms. Also, it is necessary to account for the physiological changes occurring during lactation and neonatal development, which are likely to impact Mn dosimetry within the growing body.
In the present study, we developed a model that describes Mn dosimetry in the dam and offspring. The current effort extended a previous Mn physiologically based pharmacokinetic (PBPK) model developed for adult rats to the lactating dam and neonates using rats exposed to Mn either through the diet alone or through the diet and by inhalation (Dorman et al., 2005b) . A significant feature of this revised model is inclusion of dynamic changes in physiology and anatomy that occur during lactation and postnatal development. The objective was to improve our understanding of inhalation exposure conditions that would lead to increased target tissue concentrations in early life in rats or humans. Together with the PBPK model for Mn during gestation (Yoon et al., 2009 ), the present model will be able to contribute to addressing concerns for potential risks of Mn exposure by inhalation during intrauterine and postnatal developments.
MATERIALS AND METHODS

Study Design and Data
The present model simulates Mn exposures during lactation in rats. The model parameters were set based on the tissue Mn data from Dorman et al. (2005b) . Other studies were also used and influenced model development ( Supplementary Fig. S8 ). However, many parameters had to be estimated from this single study due to lack of information on tissue Mn in inhalation exposures during lactation. The primary purpose of the present work was to demonstrate a model development process for Mn during lactation or postnatal development. The adult model was extended to a different life stage by incorporating the critical biological or physiological processes required to describe Mn kinetics during lactation and postnatal development.
The exposure regimen in the study had both in utero and lactation exposures (Dorman et al., 2005b) . The end-of-gestation predictions from the gestation model (Yoon et al., 2009) were utilized as initial values for tissue concentrations in the lactation model. The gestation model outputs were obtained by simulating Mn exposures in rats throughout pregestation (breeding and mating) and gestation. Mn was inhaled as manganese sulfate in SpragueDawley rats that were also on a 10-ppm Mn diet during the lactation and prelactation periods (Dorman et al., 2005a,b) . The scenarios used in the studies were inhalation of either air or manganese sulfate (at concentrations of 0.05, 0.5, or 1 mg Mn/m 3 ) for 6 h/day, 7 days/week. The inhalation concentrations used in the study were much higher than the plausible environmental exposure concentration and were closer to the occupational exposure (Dorman et al., 2005a) .
The inhalation exposure began 28 days prebreeding and continued through mating (up to 14 days); pregnancy exposure was from gestation day (GD) 0 (sperm plug positive) to GD19. Gestation was modeled as lasting 22 days, so the dam was kept without exposure 2 days before parturition, which was designated as postnatal day (PND) 0. Inhalation exposure during lactation lasted from PND1 (1 day after parturition) through PND18 for the dam and from PND1 to PND19 for the pups. The dam and the pups were exposed to manganese sulfate together for 17 days, and the pups were exposed without the dam for one additional day on PND19. Maternal tissue concentrations were measured on PND18. The pups were weaned after the dam was killed on PND18. The neonatal tissue concentrations were determined at three time points during the inhalation period, i.e., PND1, 14, and 19. Maternal and neonatal tissues were collected after the cessation of the 6-h exposures. Postexposure measurements were taken on PND45 and PND63 after cessation of exposure on PND19.
Model Structure
The Mn model structure was modified from an adult rat model ) that successfully simulated dietary and inhalation Mn exposures in rats. The dam and pups had the same descriptions for tissue compartments including lung, nose, brain, bone, liver, blood, and the rest of body as a lumped compartment (Fig. 1) . The dam has one additional compartment, mammary gland. Abbreviations for model parameters are given in parenthesis in the text and tables with subscripts as necessary; X indicates either dam or pup, D stands for dam, and P represents pup. All the model simulations were run using acslX version 2.4 (AEgis Technologies Group, Inc., Huntsville, AL). Model code in CSL file format is provided in the ''Supplementary Data'' section.
The dam and pups were exposed to Mn either from diet or from diet and inhalation (Fig. 1) . Dietary Mn uptake was described as a direct transfer process from the gut into the liver at a constant rate (Kdiet x ) based on Mn concentration in food and daily food consumption rate. Only a limited fraction of Mn in diet was absorbed into the body (FdietUp x ). Dietary Mn intake in the pups began on PND17 when they started to consume solid food. Milk was another source of Mn exposure to pups. Free Mn in mammary gland tissue was transferred into milk through a diffusion process described by a clearance term Clmilk (l/h). Milk Mn was then transferred into the pup liver at a constant rate (kmilk) with a degree of fractional uptake (FdietUp P ).
Mn particles were inhaled and deposited onto the lungs, nasal respiratory, and nasal olfactory epithelium. The majority of Mn from particles deposited on the nasal epithelium was absorbed into systemic blood, while a small portion was directly transferred to the olfactory bulb. Pulmonary-deposited Mn was either absorbed into lung tissue or transferred into systemic blood to be distributed to the rest of the body. Elimination of Mn was only through the bile (Kbile x ).
Mn in tissues consists of either free (Mn f ) or bound (Mn b ) Mn. Mn is absorbed and circulates in the body as the free form. Mn is stored or incorporated in the tissue components as the bound form. Both free and bound forms are present in the tissue. Mn binding is a reversible, but saturable process, the rate and extent of which is determined by a maximum binding capacity (Bmax tissuex ) and association and dissociation rate constants (Ka tissuex and Kd tissuex , respectively) in each tissue. To describe differential increases in Mn concentration in specific brain regions, three brain regions were described in the model with differing degrees of influx and efflux rates (Kin regionx and Kout regionx ). The striatum, cerebellum, and olfactory bulb were selected based on the criteria of being a target for Mn neurotoxicity, a representative of general brain tissue, and a tissue with likely contributions from direct olfactory transport, respectively .
Although some modifications for lactation and postnatal development in rats were made, the basic concepts and structures present in the adult model were retained. Table 1 lists Mn-specific model parameters with the changes made for lactation and postnatal growth. Modifications from the adult model were made only when there was sufficient rationale based on known changes in homeostatic mechanisms for Mn during lactation or postnatal development. In some instances, the need to change certain model parameters was justified on the basis of knowledge of control of the uptake of other essential elements during these early life periods. Due to limited data availability, these changes were made sequentially, using control group data to estimate lactation-specific parameters under normal steady-state dietary conditions with recalibration of the model by adjusting inhalation exposure-specific changes appropriately for each life stage. The process of parameterization used to develop the final model parameters are detailed in the ''Supplementary Data'' section ( Supplementary Fig. S8 ).
Model Parameterization
Our approach with Mn in the developmental and neonatal period has been to develop coordinate models for gestation and lactation. Preliminary versions for both periods were completed to ensure the smooth hand-off of tissue structures and tissue concentrations from the gestational period to the neonatal, lactation period. The end-of-simulation time point for gestation (specifically, GD22 values) provided the PND0 values both for physiological and Mn-specific parameters (Yoon et al., 2009 ).
Mn-Specific Parameters
To the extent possible, parameters from the adult rat model were utilized throughout. These values and changes required for the neonatal rat and lactating dam are in Tables 1 and 2 .
Mn Particle Deposition in Inhalation Exposure
The deposition patterns for total nasal cavity and lung epithelium were simulated using the Multiple Path Particle Dosimetry Model model program based on Anjilvel and Asgharian (1995; v.2 .0, The Hamner Institutes, http:// www.thehamner.org/technology-and-development/technology-transfer/) with a particle size 1.05 lm (geometric mean of count median diameter), density of 2.95 g/cm 3 , and geometric SD of 1.5 (determined during the studies by Dorman et al., 2005a,b) . Fractional deposition for nasal olfactory deposition was calculated from the estimated total nasal deposition multiplied by the olfactory airflow fraction of 15% (Kelly et al., 2001; Kimbell et al., 1997) based on the observation that deposition in olfactory epithelium is proportional to olfactory airflow as described in the adult model . From these considerations, the fractional deposition of Mn particles (as manganese sulfate) in nasal respiratory, nasal olfactory, and lung regions was 0.412, 0.073, and 0.136, respectively. This deposition pattern was applied both for the dam and the pups.
Lactating Dam
Parameters for tissue binding, partition, and brain uptake. The maternal model has eight compartments including lung, nose (respiratory and olfactory), brain, liver, bone, blood, mammary gland, and rest of body. The mammary gland, not present in the adult model , was broken out from the remaining ''rest-of-body'' tissue compartment. Tissue-binding parameters (Ka tissueD and Kd tissueD ), maximum binding capacity (Bmax tissueD , per unit tissue weight), and partition coefficient for the rest-of-the-body compartment were used for describing Mn kinetics in the mammary gland (Table 1) . All other tissue compartments were simulated as in adults, with some minor http://toxsci.oxfordjournals.org/ Downloaded from modifications regarding maximum binding capacity to achieve better concordance with the data (Dorman et al., 2005b;  Table 1 ). Tissue-binding parameters (Ka tissueD and Kd tissueD ) and brain diffusion rate constants (KinC tissueD and KoutC tissueD ) were kept the same as in adults for these maternal tissues .
Mn uptake in the gut. The major change made for the lactating dam was increased intestinal absorption during lactation, a process that likely serves as a compensation for losses due to metal transfer from the dam through milk (Segués et al., 1987) . Fractional Mn uptake (FdietUp D ) estimated for adults on a 10-ppm Mn diet was appropriately modified over the period of lactation using a TABLE function in acslX version 2.4, which employs linear interpolation between data points (Table 1; Supplementary Table S7 ).
Mn elimination. Biliary excretion rate scalar (KbileC D ) was previously estimated for adults on a 10-ppm diet  Table 1 ). Induction of biliary excretion of Mn was included for inhalation exposures at 0.5 and 1 mg/m 3 . An induced biliary excretion rate constant (Kbile2 D ) was added to the basal excretion rate constant (Kbile D ) during inhalation to match observed data (Dorman et al., 2005b) . The use of biliary induction under Mn inhalation exposures was based on the PBPK simulation of 90-day inhalation studies in the rat on a 10-ppm diet . The degree of induction (KBinduc x ) was dependent on the inhaled Mn dose.
Milk
A ''virtual'' milk compartment was included in the model; this compartment has no formal volume, but carries a mass of Mn from the dam to the nursing pup, with a variable production rate of milk over the lactation period (Yoon and Barton, 2008) . In the present calculations, the amount of milk produced equals the amount consumed by the pups assuming no delay between the production and ingestion (Yoon and Barton, 2008) .
Mn clearance through milk. Mn transfer from mammary gland to milk was described as a diffusion process, with a first-order clearance, ClmilkC (l/h/ kg 0.75 ; Table 2 ). The clearance was estimated using the milk Mn concentrations in air-exposed control rats (Dorman et al., 2005b) . The clearance was scaled to maternal body weight 0.75 . Only free tissue Mn (Mn f ) in mammary gland moved to milk via diffusion. Since no residual milk volume was included, milk concentration was determined by dividing the rate of Mn incorporation from mammary gland into milk (RAMK, lg/h) by the milk production rate (KLac, l/h; see the scalar, Supplementary Table S7). Simulated milk Mn concentrations over the period of lactation in air-inhaled rats were consistent with the observed values in Sprague-Dawley rats on a 45-ppm diet (Keen et al., 1980) .
Growing Pups
Daily Mn dose (external dose in mg/kg/day) to the pups included three sources: milk, diet (from PND17 on), and inhalation ( Figs. 1 and 2 ).
Parameters for tissue binding and brain uptake. For growing tissues, the absolute amount of maximum binding in neonatal tissues increased proportionally with tissue volume (BmaxC tissueP , lg/kg tissue). In some tissues, the proportional increase was not enough to describe changes in Mn levels and the maximum binding capacities were increased in these tissues during postnatal development. This enhanced binding was required for bone and the . Thus, actual rates of influx and efflux into certain brain regions decreased with age in the pups in the current model. Tissue-binding parameters in the dam and pups (Ka lung and Kd lung ) were adjusted to fit the observed lung Mn concentrations in the basal state (Dorman et al., 2005b ; Table 1 ). Partition coefficients were kept the same as in the adult tissues both for maternal and neonatal tissues .
Developmental changes in Mn elimination. Some pharmacokinetic parameters in young pups ( ) from PND14 to PND23. Since basal biliary excretion rates are continuously changing during postnatal development following the pattern defined by KBP, the degree of dose-dependent biliary induction was modified using the given equation, which gives the degree of induction inversely proportional to the basal biliary excretion rate of Mn.
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at CIIT on August 13, 2015 http://toxsci.oxfordjournals.org/ Downloaded from different from those in the adult rat, including a low basal level of biliary excretion of Mn (Ballatori et al., 1987) and a higher intestinal absorption of Mn during the early postnatal period (Keen et al., 1986) . The low level of biliary excretion and its rapid increase during late lactation were captured using a biliary excretion rate constant modifier, KBP ( Table 2 ). The biliary excretion rate constant for Mn was scaled to body weight 0.75 using the adult scalar (KbileC adult ¼ 0.0028) and then further modified by multiplying the value by KBP, so that there is almost no basal Mn excretion during the first 2 weeks of postnatal life, with the excretion rate reaching adult levels rapidly around PND17 (Ballatori et al., 1987;  Supplementary Fig. S6 ). The equation for varying KBP is in Table 2 . In the presence of inhalation exposure, induction of biliary excretion of Mn was also included for young animals. Pups are able to excrete excess Mn in early postnatal days during which their normal biliary excretion rate was otherwise very low (Ballatori et al., 1987; Kostial et al., 2005;  Table 2 ). Biliary induction in pups was included to achieve an Mn biliary excretion level in accordance with the tissue Mn levels reported in the pups exposed to Mn by inhalation (Dorman et al., 2005b) . The increase in biliary excretion rate (Kbile2 P ) was added to Kbile P . Since the basal biliary excretion rate for Mn is continuously changing during the postnatal growth following the pattern defined by KBP (Table 2 ), the degree of biliary induction cannot be described as a constant fold of increase compared to the basal biliary excretion rate. Therefore, the extent of induction (KBInduc P ) was adjusted using KBP and RE, an induction degree modifier during postnatal growth, as described in Table 2 . With this adjustment, the degree of induction is inversely proportional to the basal biliary excretion rate. The induction was also dependent on the inhaled Mn dose as in the dam or adults. Enhanced biliary induction in the pups was applied during the inhalation exposure.
Developmental changes in Mn uptake in the gut. Mn absorption is higher during early postnatal development with a rapid transition to the adult level at around PND16 to PND18 (Keen et al., 1986) . Therefore, fractional uptake in the pups (FdietUp P ) was increased to 20-fold higher than that in adults before PND16 based on tissue Mn data in pups (Dorman et al., 2005b) . Absorption efficiency was rapidly decreased to the adult levels at around PND21. The changing pattern was simulated using the equation for FDP, which modifies the fractional uptake level in pups during postnatal development (Table 2 ; Supplementary Fig. S5 ). This enhanced uptake may be related to either maturation of processes in the GI tract or altered bioavailability of Mn in milk versus solid diet.
Extended retention of Mn in neonatal GI tissue. Increased absorption and extended retention of Mn in gut tissue (Keen et al., 1986) have been attributed to both the anatomical and functional immaturity of the GI tract. The GI development pattern was included by extending Mn retention in the enterocytes compared to adults (Table 2 ). Increased retention in the GI tissue (enterocytes) was included in the model with a higher maximum binding capacity in the GI tissue as part of rest-of-the-body compartment. Coordinately, there were changes in gut absorption (FdietUp P adjusted by FDP) for early postnatal days. This binding capacity was modeled to rapidly decrease around initiation of food intake based on the fact that the higher absorption ability rapidly disappeared around this time (Keen et al., 1986) and on the GI tract development pattern (Walthall et al., 2005) . This changing pattern was expressed using the equation for the neonatal maximum binding capacity modifier, XOTH (Table 1) . Since the current model lacks a GI tract compartment, the changes were made for the rest-of-body compartment, in which GI tissue was included.
Loss of Mn from GI tissue during early postnatal period. In addition, a slower enterocyte turnover rate in pups compared to adults and the resulting gradual loss of Mn retained in enterocytes (as part of rest-of-the-body compartment) were included. These changes were maintained until approximately the third postnatal week with a rapid increase occurring around PND17 based on the GI tissue maturation patterns (Walthall et al., 2005) . The loss of Mn due to enterocyte turnover was described as a loss from bound Mn in enterocytes (as part of rest of body) using a first-order rate constant (Kloss; Table 2 ). This rate constant (Kloss) was varied using the equation for KLP according to the degree of GI tissue maturation and the resulting changes in enterocyte turnover rate during development (Table 2) . Hence, the rate of loss was slower before PND14 and rapidly reached the adult level after 3 weeks postpartum. After maturation of the GI tract, there was no need to account for this slower turnover rate of enterocytes. Thus, fractional uptake after the third postnatal week was based on adult enterocyte turnover rate, so FdietUp P became equal to FdietUp D with FDP being 1.
Changes in tissue-binding parameters in neonatal bone. Bone is a storage site for Mn during intrauterine development with a higher tissue-binding capacity compared to adults (Enomoto and Hirunuma, 2001 ). Hence, maximum binding capacity of the bone gradually decreased from this high level with age after birth. An exponential equation (XBO) was multiplied with BmaxC boneP to describe this gradual decrease in capacity during growth (Table 1 ). This decrease may reflect the decreasing Mn needs of the bone and/or loss of importance as an Mn storage site due to changes in bone formation processes during postnatal development. Bone mineralization begins during gestation and continues after birth, a process which is reflected in shifts among the volume and weight fractions of skeletal components such as mineral and water (O'Flaherty, 1991) . Bone mineralization and growth processes are reported to be almost complete around the time of sexual maturity in rats (O'Flaherty, 1991) .
Transient changes in tissue-binding capacity in neonatal liver during inhalation exposure. For neonate inhalation exposure simulations, a transient increase in tissue maximum binding capacity in the liver was introduced for exposures at 0.5 and 1 mg/m 3 (Table 2 ). This alteration was based on the assumption of a potential increase in Mn level in the liver due to the immaturity of the transporters responsible for biliary excretion of Mn and other metals in neonates. The adjustment was applied during the inhalation exposure period to match the observed liver Mn concentrations in neonates (Dorman et al., 2005b) .
Physiological Parameters
Physiological parameters are provided in Table 3 along with the sources from which they were obtained or modified. Data for Sprague-Dawley rats were selected for incorporation in the model whenever possible. Data collected from nonanesthetized rats were the preferred sources. Priority was given to the individual data from one study rather than using compiled data. For several model parameters, a specialized TABLE function was applied to describe the continuous changes of rat physiology by interpolating data points reported for several discrete time points during lactation and postnatal development.
Lactating Dam
The description of lactation physiology in Sprague-Dawley rats was adapted from Gentry et al. (2004) , Mirfazaelian et al. (2007) , Rodriguez et al. (2007) , and Yoon and Barton (2008) , and modified to be consistent with the Mn inhalation study design (Dorman et al., 2005b) . Physiological parameters on PND0 were matched with the GD22 values in the gestation model (Yoon et al., 2009) .
Maternal body weight changes were incorporated into a TABLE function based on published values for Sprague-Dawley rats (Shirley 1984; Supplementary Table S1 ). The changes were similar to the observed body weights during lactation in Dorman et al. (2005b) . The postpartum body weight of the dam predicted from the gestation model, which was defined as dam body weight at the end of gestation excluding the placenta and fetuses, was used as an initial body weight (BWi) at the beginning of lactation (PND0).
Mammary gland volume as a fraction of body weight was incorporated in the model using a TABLE function to describe its volume increase during lactation (Supplementary Table S3 ). The volume of mammary gland was 3.73% of total body weight of the dam on GD21 in Sprague-Dawley rats and 4.9% of her postbirth body weight (Rosso et al., 1981) . Thus, the fractional mammary volume was 0.049 on PND0 and subsequently increased following the trend reported for lactating Wistar rats (Hanwell and Linzell, 1973) .
As with the mammary gland, PND0 maternal liver volume was calculated using the relative volume on GD22 with respect to postpartum weight as the PND0 starting value in the TABLE (Supplementary Table S4 ). The changing pattern of maternal liver volume during lactation was based on data from Hanwell and Linzell (1973) . Volumes for maternal bone, lung, and blood were assumed to change in proportion to body weight during lactation. Tissue volumes as a fraction of postpartum body weight of the dam (BWi) were used as volume scalars in the lactating adult for bone, lung, and blood. However, brain volume remained constant during lactation, and, was calculated by multiplying postbirth weight (Yoon et al., 2009 ) and brain volume scalar on GD22 as described above for bone and two other tissues (Yoon et al., 2009 ). Brain regional volumes as fractions of total brain were adopted from the values used in the adult model . Volume of the nose was calculated from the surface area and tissue thickness of the nasal cavity (Conolly et al., 2000; Menache et al., 1997) . The surface area for the nasal cavity was scaled to body weight 0.75 . Temporal changes in maternal cardiac output (QC, l/h) were based on a changing pattern for this parameter observed in anesthetized Wistar rats (Hanwell and Linzell, 1973) , with a starting value based on cardiac output data observed in nonpregnant adult conscious Sprague-Dawley rats (Dowell and Kauer, 1997) . Values for cardiac index (QCI, l/h/kg) used in a TABLE function are shown in Supplementary Table S2 . Alveolar ventilation rates (QP) during lactation were assumed to be equal to cardiac output and scaled in the same way (QPI, l/h/kg).
Blood flow to mammary gland (QMC, as fraction of cardiac output) was incorporated using a TABLE function based on the changing values of this parameter during lactation seen in Wistar rats (Hanwell and Linzell, 1973; Supplementary Table S5) . To simulate fractional blood flow to the liver (QLiv), the GD22 value was employed as the PND0 starting value and then the changes during lactation (QLivC, as a relative flow to cardiac output) were modeled according to the pattern reported in Wistar rats using a TABLE function (Hanwell and Linzell, 1973; Supplementary Table S6) . Fractional blood flows to bone (QBoneC) and nose (QNoseC) were the same as in adults (Brown et al., 1997; Nong et al., 2009 ). Blood flow to maternal brain remained constant during lactation and was calculated using fractional brain flow for adults (QBrnC, Brown et al., 1997) and initial cardiac output on PND0.
Food intake for the dam was adapted from the same study from which the body weight data were obtained (Shirley, 1984) . Since the study reported the amount of food consumed by the dam and pups together, the rate of food intake by the dam only was calculated as described in Yoon and Barton (2008) .
Growing Pups
Litter size (N) was culled to eight pups throughout lactation. Growth equations for maturing Sprague-Dawley rats were employed to describe body weight and the volumes of liver, lung, and brain in developing rats (Mirfazaelian et al., 2007) . GD22 tissue weights were adopted as initial (PND0) birth weights of the tissues in the equations from Mirfazaelian et al. (2007) . Rat skeletal growth was based on Sprague-Dawley data (O'Flaherty et al., 1992) . The volume of bone was increased at a rate similar to that of the whole body, and bone volume was simulated as a constant fraction of body weight across age (O'Flaherty et al., 1992) . Thus, the volume of bone in growing rats was incorporated using a constant fractional volume as in adults (Brown et al., 1997) . For other tissues, such as blood and nose, for which the growth patterns were not available, their relative volumes (as a fraction of body weight) were included in the model using adult parameters (Brown et al., 1997; Conolly et al., 2000; Menache et al., 1997) . The relative volumes of the three different brain regions with respect to the total brain were assumed to be the same as in nonlactating adults and thus the same as in the lactating dam .
Cardiac output in the developing rat (QC_p) was simulated according to the approach used by Rodriguez et al. (2007) . They estimated cardiac output as early as PND10 from a rectangular hyperbola based on several references on neonatal rat cardiac output. In the current model, the same equation was also used to extrapolate cardiac output earlier than PND10 ( Supplementary   Fig. S1 ). Alveolar ventilation of the pup (QPC_p) was incorporated in the model using a TABLE function (Supplementary Table S9 ). The values were determined from Sprague-Dawley rat minute ventilation data across ages from Okubo and Mortola (1988) and considered a 33% dead space volume. This parameter choice was selected from among the references collected in Gentry et al. (2004) because a wider range of ages was covered in the study (i.e., from PND7 to PND48). Bandla et al. (1999) also reported the ventilation changes for Sprague-Dawley rats including earlier postnatal days before PND7. Their data were in good agreement with Okubo and Mortola (1988) for overlapping periods between the two studies. Thus, the alveolar ventilation for very early postnatal days (PND2.5) was inferred from Bandla et al. (1999) and then included in the TABLE function (Supplementary Table  S9 ). The ventilation-perfusion ratio during development resulting from the simulated cardiac output and alveolar ventilation in the current model was within the range of 0.88-1.68; the PND63 value was 1.22 ( Supplementary  Fig. S2 ).
The proportion of cardiac output to liver (QLivC_p) and brain (QBrnC_p) in growing rats was adapted from Stulcová (1977) and was incorporated using a TABLE function (Supplementary Tables S10 and S11). Relative liver blood flow was the sum of hepatic and portal flows (with portal flow defined as the sum of flows from stomach, small and large intestine, and spleen) found in Stulcová (1977) and Rodriguez et al. (2007) . The relative blood flow to brain was the sum of the flows for left and right cerebrum and hindbrain. Relative bone blood flow (QBone_p) was constant during postnatal growth (Brown et al., 1997) . O'Flaherty (1991) suggested that a simple relationship between bone blood flow rate and cardiac output (a constant fraction of cardiac output into the bone) was consistent with observed bone behavior with a range of bone formation states in rats.
Solid-food feeding patterns in early postnatal rats were included in the model using the data previously applied in a rat lactation model (Yoon and Barton, 2008 , converted from Redman and Sweney, 1976 , and Shirley, 1984 ; Supplementary Fig. S4 ). For weanling rats, data collected by Gentry et al. (2004) were used ( Supplementary Fig. S4 ). Gentry et al. (2004) reported that weanling rat food intake scaled across age roughly in relation to body weight 0.75 , at least for the observed age ranges of PND27 to PND60. This relationship was observed to be valid beginning as early as PND24 (Yoon and Barton, 2008) . Thus, the geometric mean of scaled food intake (scaled in proportion to BW 0.75 ) from PND24 to PND60 was used for PND24 through PND60. Before PND24, a linear regression curve based on the observed scaled food intake of pups (Yoon and Barton, 2008) was utilized. The onset of diet consumption by the pups was introduced on PND17 (Redman and Sweney, 1976;  Supplementary Fig. S4 ).
The description of rat lactation physiology was based on Yoon and Barton (2008) . Temporal changes in daily suckling rate per kg body weight of the pups were incorporated with a TABLE function (Supplementary Table S8 ). Milk production rate by the dam was set to the suckling rate by the pups assuming 100% intake by the pups.
Estimation of Mn Milk Transfer Rate
The diffusion rate of Mn from the mammary gland into milk (ClmilkC, l/h) was estimated by fitting the model to previously reported Mn milk concentrations (Dorman et al., 2005b;  Table 2 ). Two observations on PND1 and PND18 in a control group of lactating rats on a 10-ppm diet were used for this estimation (Dorman et al., 2005b) . Although the PND1 milk concentrations were determined based on stomach contents of the pups (Dorman et al., 2005b) , both the PND1 and PND18 milk Mn concentrations were very close to those reported in Sprague-Dawley rats on a 45-ppm diet (Keen et al., 1980) . Since 10 and 45 ppm of Mn in diet are both considered within sufficient dietary Mn ranges, the stomach concentration was considered to be a close representation of the actual milk Mn concentration for PND1 in a control group. Hence, both data points were utilized for estimating Mn clearance into milk. This milk diffusion rate constant was used for simulating inhalation exposures as well. 
Model Predictions
End-of-Exposure Tissue Concentration
The PBPK model was used to simulate concentrations observed in various experiments, primarily those conducted by Dorman et al. (2005b) . Mn tissue concentrations in the dam after the cessation of exposure on PND18 were predicted for each Mn-inhaled concentration (Dorman et al., 2005b) . End-ofexposure concentration was predicted in pup tissues at five different postnatal ages during or after inhalation exposure. The measurements on PND1, PND14, and PND19 were within the inhalation period, while those performed on PND45 and PND63 represent postinhalation measurements. Predicted tissue concentrations in the dam and the pups were compared to the observed data (Dorman et al., 2005b) .
Developmental Changes in Tissue Mn Concentration with or without Inhalation
Mn concentrations in striatum or liver in the pups during postnatal development were also simulated. Concentrations in the two tissues were compared between animals exposed to Mn at 0.5 mg/m 3 and air-inhaled control animals. Biliary excretion in the pups with or without Mn inhalation is compared in Supplementary Figure S7 .
External Dose of Mn through Different Uptake Sources
Mn dose via milk on the ith postnatal day (PND i ) was calculated using the difference between the amounts of milk Mn transferred into the suckling pups from PND0 to PND i and the amount from PND0 to PND iþ1 . Only the fraction of Mn absorbed from the milk into the pup was considered as the amount transferred. Dietary dose was calculated using the daily food consumption rate, the Mn concentration in diet (DDiet, 10 ppm), and the fraction of Mn uptake in the gut (FdietUp x ). Mn input via inhalation was determined by alveolar ventilation rate and inhaled Mn concentration, appropriately adjusted for the inhalation exposure duration and regional retention.
Calculation of Daily Dose Metrics
The 24-h cumulative area under the curve (AUC) for Mn concentration in striatum and blood were simulated both for the dam and pups on those postnatal days where concentration data were collected. Similar to calculating daily dose, daily AUC (24-h AUC) on PND i was calculated using the difference between the AUC from PND0 to PND iþ1 and that from PND0 to PND i . AUCs on PND1 and PND14 were calculated for the dam since they were sacrificed after PND18, whereas PND1, PND14, PND19, PND45, and PND63 AUCs were calculated for the pups. AUC values for the nonlactating adult female were based on the prepregnancy values (Yoon et al., 2009) .
Model Evaluation
The adequacy of the present model and corresponding parameters were assessed in terms of testing whether the model was able to consistently describe the available pharmacokinetic data of Mn during lactation (Dorman et al., 2005b; Keen et al., 1980) . Although model evaluation for the current model was not conducted rigorously from a statistical perspective, the evaluation criteria we used were considered usual for a model of this complexity. To evaluate the current model, the correspondence between the data points for tissue Mn and model-simulated values on the selected postnatal days were examined visually to ensure that the simulations were consistent with trends over time and achieved tissue concentrations. With the diversity of studies and tissue concentration results, no attempt was made to provide a global optimization of all parameters. Then, the shape of simulated curves during lactation and postnatal development were assessed to determine whether they recapitulated the experimental time course curves. In some cases of poorer agreement between the observed data and model simulations, discussions for potential reasons for the less correspondence are provided. However, agreement between the experimental data and model simulations were good in general and especially accurate in target brain region. The goodness of the model prediction evaluated based on these criteria was considered to be reasonable for the available data sets. Further efforts to refine model parameters or access goodness of fit are likely to require detailed kinetic studies that would be designed based on predictions from the present model.
Sensitivity and Uncertainty Analysis
A semiquantitative uncertainty analysis of the present model was performed through a combination of sensitivity analysis and a qualitative evaluation of End-of-gestation value was adapted from the gestation model (Yoon et al., 2009) . It was calculated using the postbirth weight of the dam, which was the total body weight of the dam at the end of gestation excluding fetuses and placenta weight. The relative impact of the model parameter to the dose metric of interest, i.e., total Mn concentration in neonatal striatum (Ctot stP ) or AUC for total Mn in neonatal striatum (AUC stP ) on selected postnatal days, PND8 and PND18, was examined using the sensitivity analysis. The analysis on PND8 provides information on parameter sensitivity when the food source is solely milk, whereas on PND18, the food source is a combination of milk and solid diet. The sensitivity coefficients (SCs) were calculated for all the model parameters, but those with SC greater than 0.2 were reported (Table 4) . They were categorized into three levels that represent the level of influence of the given model parameter to the prediction of the internal dose metric as described in the gestation model (Yoon et al., 2009) The uncertainty of the model parameters with medium or high impact on the selected dose metric was evaluated qualitatively. The evaluation was based on the availability of the appropriate data for the relevant life stages, i.e., lactation and postnatal periods and the availability of the data or the information for Mn. The uncertainty was categorized into three groups following the same criteria used in the gestation model (Yoon et al., 2009) .
RESULTS
Milk and Maternal Tissue Mn
Simulated milk Mn concentrations on PND18 (Fig. 2) were consistent with the observed values both for normal lactation (Keen et al., 1980) and inhalation exposure conditions (Dorman et al., 2005b) . Keen et al. (1980) determined milk Mn level in Sprague-Dawley rats on a 45-ppm diet, which was considered to provide sufficient Mn to the rats. The dietary Mn in Dorman et al. (2005b) of 10 ppm also falls in the sufficient range of Mn in diet. Assuming that Mn secretion into milk within the sufficient Mn diet range would be similar, the concordance of the simulated Mn concentrations with the reported data (Keen et al., 1980) supports the accuracy of the estimated milk clearance, ClmilkC. Maternal tissue concentrations were determined on PND18 after the cessation of the last exposure (Dorman et al., 2005b) and agree well with the simulations from the PBPK model (Fig. 3) .
Predicting Neonatal Brain and Liver Concentrations
Because the striatum is the target tissue for Mn neurotoxicity (Aschner et al., 2005) , the correspondence between the observed and simulated Mn concentrations in this tissue on PND19 was considered the most important concentration in the current modeling effort. The simulated striatal concentration at the end of exposure (Fig. 4) was consistent with the data (Dorman et al., 2005b ). The rise in Mn level in the olfactory bulb during inhalation and the postexposure decline were also recapitulated by the model. Since whole brain concentrations were reported for PND1 and PND14 (Dorman et al., 2005b) , these values were compared to the simulated cerebellum level. Simulated end-of-exposure cerebellum levels were consistent with the experimentally determined Mn concentrations in the whole brain and in this brain region (Dorman et al., 2005b) . The simulated neonatal liver Mn levels at the end of exposure at each inhaled Mn concentration (Fig. 5) were consistent with those determined by Dorman et al. (2005b) both during the exposure and postexposure periods.
Predicting Other Neonatal Tissue Concentrations
Although agreeing reasonably well with the data, there were inconsistencies between simulations and the data (Dorman et al., 2005b) for other tissues (Fig. 6) , especially for lung and blood. Some of the simulated neonatal lung concentrations were higher than the data. This discrepancy may be related to lung deposition and/or the absorption of the deposited Mn particles into the lung tissue and systemic blood. Currently, the lung deposition in the pups is the same as the adults, ignoring morphological differences in the lung anatomical structure between adults and developing pups. With the incorporation of refined descriptions of the particle deposition and subsequent transfer into the systemic blood, the model might better simulate the lung and blood concentration.
The simulated bone concentrations are consistent with the observations in Dorman et al. (2005b) , except for PND1. It should be noted that bone collected for PND1 was skullcap, while femur was collected for later postnatal ages. Although the changes in bone composition during growth are accounted for by varying Mn maximum binding capacity in this tissue, potential differences in the bone mineralization rate in different types of bones have not been included in this present model structure. Hence, the discrepancy between simulated PND1 bone concentration and the data may be, at least partly, due to the nature of the samples collected at the different ages.
Age-Dependent Changes in Mn Tissue Concentration Under Inhalation Exposure
Simulated Mn concentrations in the striatum and liver in pups during postnatal development (Fig. 7) are plotted against measured concentrations with or without inhalation exposure (Dorman et al., 2005b) . Mn tissue levels in growing rats are regulated by several factors, including both physiological and pharmacokinetic changes. These changing variables give rise to complex temporal relationships in liver and striatum Mn levels. The reduction in manganese tissue concentration around PND14 in control pups is likely related to the relative decrease in available Mn levels in milk and diet during this postnatal period. The level of absorbed Mn from milk and/or diet appears to be lower around the second postnatal week, before the pups are completely weaned (Fig. 8) , a factor that could partially be responsible for lower tissue Mn. After about PND17, available Mn from food increases, but simultaneously fractional uptake starts to rapidly decrease in the gut and basal biliary excretion rate sharply increases toward the adult level. Hence, the tissue Mn levels approach adult levels (Fig. 7) . Maturation of GI tissue and the resulting faster turnover rate of enterocytes likely result 
Note. na, not applicable. Asterisk represents an SC smaller than 0.2.
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in increased Mn loss from the body. These coordinated changes in Mn processing are likely responsible for changes in tissue levels around the time of food source switching. These changes that determine Mn absorption and excretion or loss from the body all occur around the time of food source transition from milk to solid diet, probably related to differences in Mn levels and/or Mn forms present in milk and diet (Ballatori et al., 1987; Keen et al., 1986; Walthall et al., 2005) .
Comparison of External Dose to the Pups through Different Uptake Sources
Daily Mn dose via milk, diet, or inhalation, if applicable, were compared on five different selected postnatal days (Fig. 8) . Mn in food or milk that was absorbed into the body through gut absorption was considered as dietary dose or milk dose, respectively. Mn delivered to the body from nasal and pulmonary deposition was considered as inhaled dose. Hence, external dose was determined by Mn concentration in milk, diet, and the inhalation chamber in conjunction with fractional absorption from gut, ventilation rate, and nasal or pulmonary deposition. The current model for soluble Mn-containing dusts has complete absorption of the Mn deposited in various regions of the respiratory tract. Since the dam and pups were exposed to Mn via inhalation concomitantly, the pups were exposed to Mn both through inhalation and through milk in which the Mn level was increased by inhalation. For comparison, external dose to the maternal body was also illustrated for PND1 and PND14 before they were killed (Fig. 8) . The relative contribution of each source changes during postnatal development. On PND1, milk was the only Mn source to the suckling pups since they were killed without inhalation on PND1. Mn intake through milk on PND1 was much greater than total Mn intake at later ages, even under highconcentration Mn inhalation. Higher gut absorption in the early neonatal period was mainly responsible for the greater   FIG. 2 . End-of-exposure milk concentration on PND18. Mn in milk was determined at the end of exposure on PND18 in maternal milk. Data are represented using mean ± SEM (Dorman et al., 2005b) . Model-simulated milk concentrations on PND18 are plotted as a solid line. intake of Mn from milk in the PND1 pups. The PND14 intake comparison reflects decreasing milk consumption per unit body weight. Although, the absolute volume of milk produced by the dam is still increasing, the neonatal growth rate exceeds this increase in milk volume. Thus, relative daily Mn intake per unit body weight (mg/kg/day) on PND14 is reduced compared to PND1, even though absorption is still high on PND14. After weaning, the relative contribution of inhaled versus dietary Mn in determining total external dose becomes similar to the dam. However, the daily Mn dose to the dam through the diet is much higher than that in nonlactating adults as the dam has increased food intake during lactation by up to threefold (Shirley, 1984) . At PND14, Mn intake from milk is greater than Mn intake from inhalation at all but the highest inhaled concentration (1 mg/m 3 ). At PND19, on the other hand, the Mn intake from inhalation exceeds the Mn intake from diet at 0.5 mg/m 3 and above.
Comparison of Internal Exposure Levels between the Dam and Pups
The 24-h AUCs for striatum and blood (lgÁh/g) were compared between the dam and pups on those postnatal days where concentration data were collected (Fig. 9) . The comparison of the internal dosimetry gives an idea of the relationship of maternal and pup exposures by inhalation. This information, which is not readily available from an external dose comparison alone, is needed for a dosimetry-based risk assessment for Mn.
The relative exposure level in the target brain region striatum between the dam and pups was similar and not substantially (Fig. 9) . The suckling pups are exposed to Mn by two routes-by inhalation and by milk ingestion from the dam. Blood 24-h AUCs were compared together, since blood Mn could be used in measuring Mn body levels as an exposure marker. The 24-h AUC on PND1 with only milk exposure without inhalation was almost similar or even higher than the levels seen in PND14 and PND19 animals exposed to Mn by inhalation as well as milk (Fig. 9 ).
Although our model included a low basal biliary excretion based on the observation by Ballatori et al. (1987) and higher absorption during the early postnatal period (Keen et al., 1986) , biliary excretion had to be induced in neonates in the presence of excess level of Mn from inhalation exposure. Thus, despite minimal Mn excretion during the first 2 weeks of postnatal life in the basal state, similar levels of exposure to Mn were simulated as shown by the comparable 24-h AUCs in striatum between the dam and pups during early postnatal days (Fig. 9) . A potential decrease in absorption in the gut in response to high-Mn body burden was not considered based on the lack of intestinal regulation of iron absorption in neonates to dietary iron deficiency or iron supplementation (Leong et al., 2003b) .
Sensitivity and Uncertainty Analysis
The key parameters for total Mn concentration and AUC in neonatal striatum were identified by sensitivity analysis (Table  4 ). The internal exposure to Mn in neonatal striatum was sensitive to influx or efflux rates of Mn in the striatum along with Bmax in this brain region as in the adults . In addition, fractional uptake of Mn (FdietUp P ) in neonates, storage capacity for Mn in the neonatal GI tissue (BmaxOth P ), and some of the neonatal physiological parameters such as body weight of the pups and their striatum volumes showed high impacts on Mn exposure level in neonatal striatum (Table 4 ). The relative importance of Bmax in GI tissue was smaller in exposed animals than the control, while the importance of QP, FDepNR P , and Kbile P was greater in exposed pups. It was noticeable that several maternal parameters showed high impacts on striatum Mn in neonates. These parameters are thought to be highly influential due to their importance in determining milk Mn concentrations. Indeed, milk Mn concentrations were highly sensitive to these maternal parameters (data shown in the ''Supplementary Data'' section).
The SCs for some of the sensitive parameters were higher than 1. Generally, SC greater than 1 indicates a potential amplification of input errors in the model predictions. In the present analysis, SCs were greater than 1 for, fractional uptake of Mn in neonatal gut (FdietUp P ), Bmax of Mn in GI tissue (BmaxOth P ), and body weight of the pups in control animals. However, our confidences in these parameters were relatively high based on the criteria used in the present study. In the case FdietUp P and BmaxOth P , the information for developmental changes in Mn absorption in the gut and the relevant biological mechanisms underlying the observed changes are available ( Supplementary Fig. S8 ). Postnatal growth rates for SpragueDawley rats are described well in the literature (Mirfazaelian et al., 2007) .
The uncertainty evaluation indicated that further research on the mechanisms of Mn transport and the role of Mn in neonatal brain can contribute to increasing our confidence in the predicted Mn internal dose metrics in target brain region during postnatal development. In addition, further understanding of the secretion of Mn into milk and absorption of Mn in the gut along with the following transport mechanisms of Mn across the GI tissue under various exposure conditions in neonates will provide critical information for addressing the concerns for potential risks of Mn during early life stages.
DISCUSSION
The present model reproduced Mn tissue concentration changes during the neonatal period both in the basal state and for inhalation exposures in rats (Dorman et al., 2005b) . The correspondence of the model prediction with the data indicates that the model captures and appropriately incorporates important determinants of Mn kinetics during the postnatal growth periods both in the normal state and with the exposure to Mn by inhalation.
One notable difference between the lactational or neonatal and the adult model was the incorporation of dynamic changes during early life both in terms of physiology and of various physiological determinants of Mn kinetics. To appropriately consider the dynamic nature of the postnatal period, we maintained basic homeostatic mechanisms across life stages, while varying the degree to which they contribute during lactation and postnatal development. In this way, the lactation model served to validate aspects of the Mn PBPK model for adults. The basic concepts for adjusting the adult kinetics to suit the neonatal period include changes in gut absorption of Mn during development, the ability to control the degree of excretion in early ages in response to body burden, and changing needs for Mn in different tissues during postnatal development. The alterations made for the current model were consistent with physiological changes that lead to the maturation of processes controlling Mn disposition in the body. For some parameters, these changes were simply accomplished by scaling to body weight or tissue volume, whereas more complicated modifications were required for other parameters to appropriately simulate tissue Mn dosimetry in growing pups as well as in the lactating dam.
The recently developed Mn PBPK model had saturable tissue binding that explained Mn deposition and variable rates of elimination for low versus high intake levels . Tissue binding considers Mn incorporation into enzymes, cofactors, and other tissue Mn stores . The rates of association and dissociation of Mn were kept constant across life stages, whereas maximum binding capacity (Bmax) varied, reflecting the changing level of the macromolecular Mn stores during development. The only exception was association and dissociation rates in developing brain, which required higher incorporation rates into bound states. This difference probably reflects anatomical and/or biochemical changes occurring in the brain tissue during postnatal development. Higher Mn uptake into brain in PND5 pups compared to adults indicates increased Mn requirements for brain development (Takeda et al., 1999) . Changes in maximum binding capacity in tissues were proportional to tissue volume increases in most cases. In some cases, this value of maximum binding capacity per gram tissue (BmaxC) was varied during the postnatal period to correlate with observed concentrations. These changes likely reflect tissue-specific developmental characteristics that affect Mn kinetics in those tissues. For instance, Bmax in the bone was highest at birth and then declined. These changes in parameters for binding may reflect bone maturation processes, which are thought to involve rapid changes in mineral deposition in this tissue (O'Flaherty, 1991) . In this case, the Bmax change could not be expressed as a simple relationship with tissue volume changes.
Rates of influx and efflux in certain brain regions in the model decreased with increasing pup age. These influx or efflux rates may depend on the maturation level of metal transport systems across the blood brain barrier (BBB), which are considered potential mechanisms of Mn transfer across the BBB (Erikson et al., 2007) . Mn appears to share the same transport mechanisms in brain with iron and other metals (Garcia et al., 2006) including transferrin/transferrin receptor (TfR) and divalent metal transporter-1 (DMT1; Erikson et al., 2007) . Transport systems for essential metals across the BBB during the early postnatal period appear to be comparable to adults or may even be higher as suggested by an upregulated expression of transferrin receptors (Moos and Morgan, 2002) FIG. 8. Daily external dose to the pups during inhalation exposure: comparison among milk, dietary, and inhaled doses. Daily dose via each Mn source was calculated for selected postnatal days and expressed as mg Mn taken in through the specified source per kg body weight during a 24-h period. INH represents the inhaled Mn dose. Dietary and lactational doses were continuous during the 24 h, whereas a 6-h exposure duration was used for the inhaled Mn dose. Inhalation was from PND1 to PND19 in the pups and from PND1 to PND18 in the dam. PND1 pups were killed without inhalation (Dorman et al., 2005b) ; hence, no inhalation was simulated for the dam and pups on PND1.
and fully expressed DMT1 in early postnatal rat brain (Siddappa et al., 2002) . The BBB is thought to be immature in young animals, which may lead to higher brain uptake of Mn in neonates. However, age-dependent transporter expression may be an equally important contributor for efficient Mn transport into brain.
Several findings regarding Mn kinetics or homeostatic control mechanisms in neonates have raised concerns about potentially enhanced Mn delivery to neonatal brain (Aschner et al., 2005) . These factors include enhanced Mn delivery to the brain (Takeda et al., 1999) , lower basal biliary excretion of Mn during the early postnatal period (Ballatori et al., 1987) , and efficient absorption of Mn in the neonatal GI tract (Keen et al., 1986) . Neonatal rats developed higher brain Mn level following similar high-dose oral exposures compared to adults, although the interpretation of the findings in relation to neurotoxicity would require some caution (Dorman et al., 2006) . However, information is more limited regarding the potential risks in neonates exposed to airborne Mn. Recently Dorman et al. (2005b) investigated Mn pharmacokinetics in rats exposed to Mn via inhalation during development, the results of which were reproduced using the present model. The experimentally determined Mn concentration in neonatal striatum and the model-predicted AUC for this brain region did not imply significantly higher exposures in the pups when compared to those in adults (Dorman et al., 2005b; Fig. 9) up to the inhaled dose of 1 mg/m 3 . Although further elaboration of the dose-response relationship between brain Mn levels and neurotoxicity is required for addressing the potential vulnerability of neonatal brain to inhaled Mn, these present results indicate that neonates are not at an especially increased risk to striatal Mn due to differences in pharmacokinetic factors.
In adults, increased Mn body burden due to inhalation is mitigated mostly by enhanced biliary excretion . Neonatal rats appear to enhance their biliary excretion when challenged with excess Mn through the oral route (Ballatori et al., 1987) . Whether the same homeostatic control would be applicable for Mn exposure through inhalation was addressed in the present modeling by comparing simulated Mn tissue levels with or without biliary induction in the pups. Model-simulated tissue Mn concentrations were well above the observed tissue Mn in pups exposed to airborne Mn (Dorman et al., 2005b) when enhanced biliary excretion was not included in the model. Thus, the induction of dose-dependent biliary excretion in neonatal rats appears to occur to an extent comparable to adults for inhalation exposure over 0.5 mg/m 3 Mn. The good agreement with the observed data for modelpredicted Mn internal exposure in the striatum implies that similar control is available for inhaled Mn burden in neonates as in adults. A cross-fostering study by Kostial et al. (2005) also supports significant induction of biliary excretion of Mn in the neonatal rat.
Alteration of the absorption of Mn in the GI tract is not likely to be an important control mechanism in response to inhaled Mn. However, it is important for maintaining Mn homeostasis in neonates. Although several studies indicate that most of the Mn administered orally is efficiently absorbed and retained in the neonatal body, it is debatable whether the majority of this Mn becomes available to systemic tissues (Aschner et al., 2005; Keen et al., 1986) . Keen et al. (1986) demonstrated that the majority of However, there were some deviations between experimental observations and model predictions in other tissues. Predicted neonatal blood concentrations tended to be higher than the measured value except on PND1 (Fig. 6 ). These discrepancies may be partly due to the difficulty in sampling tissues in very small animals and in a large number of animals at specific time intervals after completion of the inhalation studies. For instance, there was a variable time delay between the end of exposure and the sampling time of fetuses and pups. The sampling difficulty would especially affect tissues with rapid clearance after cessation of exposures, such as blood. Another possible reason for some discrepancies could be the nature of the tissue samples. In some cases, tissues taken from PND1 animals were different from the similar tissues taken from older rats, e.g., skullcap on PND1 versus femur in other ages and whole brain versus different brain regions (Dorman et al., 2005b) . Also, it was our intention not to make large changes in parameters that had been successful in the adult model simply to improve the neonatal model fits without adequate rationale. As more data become available on Mn pharmacokinetic changes during early life periods, the current model structure could be refined.
Overall, with the model structure and changes from the adult model as noted, the simulated maternal and neonatal tissue Mn concentrations were in reasonable agreement with the observed data (Dorman et al., 2005b) . The success in reproducing tissue Mn levels in lactating dams and neonates provides confidence that the major factors affecting the disposition of Mn in the neonatal period have been appropriately captured. Similar physiological changes over time will likely be required to describe the kinetics of other essential elements in the perinatal period.
In summary, a series of modifications made for the lactating dam and pups compared to the adult rat resulted in good agreement between observed and calculated Mn concentrations in various tissues in exposed dams and neonates. These changes were concordant with the biology of essential metals during development and the simulations matched observed maternal Mn homeostasis during lactation and changing patterns of neonatal tissue levels for both normal dietary intake and with Mn inhalation. This lactation model together with the gestation model should allow determination of the extent to which neonatal animals may be at higher risks than adults from Mn exposures in fetuses and neonates. The well-developed physiological processes that maintain Mn homeostasis in the dam and neonate together with enhanced Mn elimination with increasing inhalation exposures of the neonates suggest that the neonates are not at appreciably greater risk for increased striatal Mn compared to adults.
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